Perceived benefits: A predictor of participation in prostate cancer screening

Cancer Nursing

Volumn 21, Issue 5, 1998, Pages 349-357

  Tingen, Martha S ^a   Weinrich, Sally P ^b   Heydt, Duane D ^b   Boyd, Marlyn D ^b   Weinrich, Martin C ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American men; Free cancer screening; Perceived benefits; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CANCER SURVIVAL; EDUCATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RACE;

ADULT; AGED; ATTITUDE TO HEALTH; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ONCOLOGIC NURSING; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 0031752574     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-199810000-00006     Document Type: Article

References (48)

1. Schroder FH. Screening, early detection, and treatment of prostate cancer: a European view. Urology 1995;46:3A.
2. Slawin KM, Ohori M, Dillioglugil O, Scardino PT. Screening for prostate cancer: an analysis of the early experience. CA Cancer J Clin 1995;45(3):134-47.
3. American Cancer Society. Cancer facts and figures - 1997. Atlanta: American Cancer Society, 1997.
4. American Cancer Society. Prostate cancer update. Columbia, South Carolina Division: American Cancer Society, 1995 (winter).
5. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on cancer. CA Cancer J Clin 1993;43(2):83-91.
6. Freeman HP. Cancer and the socioeconomically disadvantaged. CA J Clin 1989;39(5):263-95.
7. Laszlo J. Prostate cancer. Res News 1994;(2).
8. Brawer MK. How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma. CA Cancer J Clin 1995;45(3):148-64.
9. Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clinicians 1993;43:42-46.
10. Wingo PA, Tong T, Bolden S. Cancer Statistics. 1995. CA Cancer J Clin 1995;45:8-30.
11. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-8.
12. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennbert JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993;269(20):2650-8.
13. McCoy C, Nielsen BB, Chitwood DD, Zavertnik JJ, Khoury EL. Increasing the cancer screening of the medically underserved in South Florida. Cancer 1991;67:1808-13.
14. Steele GD, Jessup LM, Winchester DP, Murphy GP, Menck HR. Clinical highlights from the National Cancer Data Base: 1995. CA Cancer J Clin 1995;45(2):102-11.
15. Schmidt JD, Mettlin C, Natarajan X, et al. Trends in patterns of care for prostate cancer. 1973-1983: results of surveys by the American College of Surgeons. J Urol 1995;136:416-21.
16. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health 1991;81:501-4.
17. Price JH, Colvin TL, Smith D. Prostate cancer: perceptions of African-American males. JAMA 1993;85(12):941-7.
18. Underwood SM. African-American men: perceptual determinants of early cancer detection and cancer risk reduction. Cancer Nurs 1991;14(6):281-8.
19. Underwood SM. Cancer risk reduction and early detection behaviors among black men: focus on learned helplessness. J Community Health Nurs 1992;9(1):21-31.
20. Stromborg MF, Pender NJ, Walker SN, Sechrist KR. Determinants of health-promoting lifestyle in ambulatory cancer patients. Soc Sci Med 1990;31(10):1159-68.
21. Becker MH. The health belief model and personal health behavior, Thorofare, NJ: Charles B. Slack, 1974.
22. Powe BD. Fatalism among elderly African-Americans: effects on colorectal cancer screening. Cancer Nurs 1995;18(5): 385-92.
23. Weinrich S, Coker AL, Weinrich M, Eleazer GP, Greene FL, Pre dictors of pap smear screening in socioeconomically disadvantaged elderly women. J Am Geriatr Soc 1995;43:267-70.
24. Weinrich SP, Weinrich MC. Cancer knowledge among elderly individuals. Cancer Nurs 1986;9(6):301-7.
25. Weitzel MH, Waller PR. Predictive factors for health-promotive behaviors in white, Hispanic, and black blue-collar workers. Fam Community Health 1990;13(1):23-34.
26. Pender NJ, Walker SN, Sechrist KR, Stromborg MF. Predicting health promoting lifestyles in the workplace. Nurs Res 1990; 39(6):326-32.
27. Greco KE, Kulawiak L. Prostate cancer prevention: risk reduction through lifestyle, diet, and chemoprevention. Oncol Nurs Forum 1994;21(9):1501-1511.
28. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993;118(10):793-803.
29. Weinrich SP. (1994). Interventions to increase prostate cancer screening (National Cancer Institute Grant #1-RO1-CA60561-01). Bethesda MD: National Institutes of Health, 1994.
30. Underwood SM, Hoskins D, Cummins T, Morris K, Williams A. Obstacles to cancer care: focus on the economically disadvantaged. Oncol Nurs Forum 1994;21(1):47-52.
31. Mettlin C, Lee F, Drago J, Murphy G. The American Cancer Society National Prostate Cancer Detection Project. Cancer 1991; 67(12):2949-58.
32. Catalona W, Richie J, Ahmann F, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90.
33. DeAntoni EP, Crawford ED. Prostate cancer awareness week: education, service, and research in a community setting. Cancer Suppl 1995;75(7):1874-9.
34. Catalona WJ, Smith DJ, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
35. Stromborg MF, Rohan K. Nursing's involvement in the primary and secondary prevention of cancer: nationally and internationally. Cancer Nurs 1992;15(2):79-108.
36. American Cancer Society. Cancer and the socioeconomically disadvaniaged. Atlanta, GA: Author, 1990.
37. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage of diagnosis and treatment of prostatic cancer in Connecticut. Cancer 1992;70(8):2152-8.
38. Morbidity and Mortality Weekly Report. Trends in prostate cancer -United States, 1980-1988. MMWR Morb Mortal Wkly Rep 1992; 41(23):401-4.
39. American Cancer Society. Report to the nation: cancer in the poor. CA Cancer J Clin 1990;39:263-5.
40. Demark-Wahnefried W, Catoe K, Paskett E, Robertson C, Rimer B. Characteristics of men reporting for prostate cancer screening. Urology 1993;42:269-75.
41. Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening tests for colorectal and prostate cancer data from the 1987 National Health Interview Survey. Prev Med 1990;19(5): 562-74.
42. Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and pap smear screening in U.S. women. Am J Public Health 1993;83:53-60.
43. Sherman JJ, Abel E, Tavakoli A. Demographic predictors of clinical breast examination, mammography, and pap test screening among older women. J Am Acad Nurse Practitioners 1996;8(5):231-6.
44. Myers RE. Wolf TA, Balshem AM, Ross EA, Chodak GW. Receptivity of African-American men to prostate cancer screening. Urology 1994;43(4):480-7.
45. Weinrich SP, Boyd MD, Powe B. Tool adaptation for socioeconomically disadvantaged populations. In: Stromborg M and Olsen S, eds. Instruments for clinical nursing research. 1997:20-29. Pittsburgh: Oncology Nursing Society.
46. Carmines EG, Zeller RA. Reliability and validity assessment. Newbury Park, CA: Sage Publications, 1979:43-47.
47. von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guidelines for the early detection of prostate cancer: update 1997. CA Cancer J Clin 1997;47:261-4
48. Murphy GP. Prostate cancer: here and now. CA Cancer J Clin 1995;45(3):133.